Search clinical trials for: ATR (ataxia-telangiectasia and Rad3 related protein)inhibitor,
Total 474583 results
-
University of SurreyEuropean UnionCompletedOverweight | Iron-deficiency | Nutritional Deficiency | Poor NutritionUnited Kingdom
-
Musclegen Research, Inc.CompletedAbsorption; Disorder, Protein | Analysis, Event History
-
Heilongjiang Feihe Dairy Co. Ltd.RecruitingGastrointestinal Diseases | Gut HealthChina
-
University of BolognaNovartisCompleted
-
Federal Research Institute of Pediatric Hematology...CompletedChronic Granulomatous DiseaseRussian Federation
-
University of ArkansasCompletedProtein | MetabolismUnited States
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
Leiden University Medical CenterTakeda; Netherlands Brain FoundationRecruitingTraumatic Brain Injury | Trauma, HeadNetherlands
-
Catalyst BiosciencesCompletedHemophilia A With Inhibitor | Hemophilia B With InhibitorArmenia, Georgia, South Africa, Poland, Russian Federation
-
National Institute of Cardiology, Warsaw, PolandAmsterdam UMC, location VUmc; University of Eastern Finland; Medical University...RecruitingHeart Failure | Hypertrophic CardiomyopathyPoland
-
Zhongnan HospitalRecruitingGastrointestinal CancerChina
-
Suzhou Alphamab Co., Ltd.RecruitingHemophilia A With Inhibitor | Hemophilia B With InhibitorChina
-
Christoph KönigsRoche Pharma AG; Chugai Pharma Germany GmbHRecruitingSevere Hemophilia A | Severe Hemophilia A With Inhibitor | Severe Hemophilia A Without InhibitorGermany
-
AryoGen Pharmed Co.CompletedHemophilia A With Inhibitor | Hemophilia B With InhibitorIran, Islamic Republic of
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHemophilia A With Inhibitor | Hemophilia B With InhibitorChina
-
Samsung Medical CenterSuspendedAromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea (CYP19)Polymorphism | CYP19 | Aromatase InhibitorKorea, Republic of
-
Charite University, Berlin, GermanyCompleted
-
Kathelijn FischerRadboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaboratorsRecruitingAdolescent | Child | Hemophilia A With Inhibitor | Adult | Hemophilia A Without Inhibitor | Hemophilia A, SevereNetherlands
-
Catalyst BiosciencesTerminatedHemophilia A With Inhibitor | Hemophilia B With InhibitorUnited States, United Kingdom, Taiwan, Italy, Spain, India, Turkey, Malaysia, Russian Federation, Armenia, Georgia, Hungary, Mexico, Poland, South Africa, Ukraine
-
SanofiProtein Sciences CorporationCompletedInfluenzaUnited States
-
Tulane UniversityIdeal ProteinCompletedWeight LossUnited States
-
University of PittsburghCompletedEmesisUnited States
-
Wageningen University and ResearchCompletedProtein Digestion Kinetics | Intestinal Barrier FunctionNetherlands
-
Chengdu CoenBiotech Co., LtdBeijing Friendship Hospital; Beijing Chest Hospital, Capital Medical UniversityCompleted
-
University of HohenheimCompleted
-
Rajavithi HospitalRecruitingPostoperative Outcomes | Whey Protein | Gynecological Cancer SurgeryThailand
-
National Cancer Institute (NCI)TerminatedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | Recurrent Lung Small Cell Carcinoma | Stage IIIA Lung Small Cell Carcinoma AJCC v7 | Stage IIIB Lung Small Cell Carcinoma AJCC v7 | Stage IV Lung Small Cell... and other conditionsUnited States
-
Pharming Technologies B.V.CompletedGenetic DisordersNetherlands
-
Prothya BiosolutionsCompletedAngioedemaNetherlands
-
Istari Oncology, Inc.Active, not recruiting
-
Shanghai Chest HospitalBristol-Myers SquibbCompletedNSCLC Stage IV | Checkpoint InhibitorChina
-
Charite University, Berlin, GermanyTerminatedPatients Following Gastrointestinal SurgeryGermany
-
HealthBanks Biotech Co., Ltd.UnknownPhase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein VaccineCervical Intraepithelial Neoplasia
-
University of HohenheimUniversity Hospital TuebingenCompletedBariatric Surgery CandidateGermany
-
Bursa Postgraduate HospitalCompletedContrast Agents and Oral Factor Xa InhibitorTurkey
-
University Hospital, Strasbourg, FranceRecruitingResistance to Activated Protein C in the Determination of Protein S ActivityFrance
-
UConn HealthTerminatedBreast NeoplasmsUnited States
-
Pharming Technologies B.V.University of Wisconsin, MadisonWithdrawnKidney Transplantation | Graft RejectionUnited States
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)Germany
-
Pharming Technologies B.V.CompletedGenetic DisordersNetherlands
-
SOFIERecruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Gastrointestinal CancersUnited States
-
General Hospital of Ningxia Medical UniversityCompletedPostoperative Complications | Cognitive Dysfunction | Inflammasomes | Pyrin Domain-Containing 3 ProteinChina
-
Federal University of UberlandiaUnknown
-
Fresenius Kabi Taiwan Ltd.Chung Shan Medical UniversityCompleted
-
Jiangsu Gensciences lnc.RecruitingHemophilia | Hemophilia A With Inhibitor | Male | Hemophilia B With InhibitorChina
-
Energenx Medical LTD.Recruiting
-
University of UtahCompletedMuscular AtrophyUnited States
-
Janssen Vaccines & Prevention B.V.Completed
-
Anne ChangNovartisCompletedBasal Cell CarcinomaUnited States
-
Peking University Third HospitalRecruitingType 2 Diabetes | Antidiabetic DrugsChina